Hamptons Homebuildi...
Health Care: Health Services
Genomic Health Inc. (GHDX: NASDAQ)
$37.00 0.00 | 0.00%
05/24/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 18.00M | 32.87M | 31.18M | 9.08M |
| Receivables | 22.25M | 21.08M | 14.31M | 11.12M |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 130.21M | 129.00M | 97.66M | 74.25M |
| Property, Plant & Equipment, Gross | 53.10M | 43.73M | 37.70M | 33.45M |
| Accumulated Depreciation & Depletion | 39.00M | 34.28M | 27.35M | 20.58M |
| Property, Plant & Equipment, Net | 14.10M | 9.44M | 10.34M | 12.86M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 9.42M | 4.56M | 2.85M | 994.00K |
| Total Non-Current Assets | 23.52M | 14.00M | 13.20M | 13.86M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 153.73M | 143.00M | 110.86M | 88.11M |
| Accounts Payable | 4.88M | 7.02M | 3.97M | 1.30M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 617.00K | 685.00K | 243.00K | 364.00K |
| Total Current Liabilities | 25.34M | 26.14M | 21.57M | 18.71M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 2.07M | 1.50M | 3.18M | 891.00K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 2.07M | 1.50M | 3.18M | 891.00K |
| Total Liabilities | 27.41M | 27.64M | 24.75M | 19.60M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 126.33M | 115.36M | 86.11M | 68.51M |
| Common Par | 3.00K | 3.00K | 3.00K | 2.00K |
| Additional Paid In Capital | 313.92M | 281.15M | 259.72M | 246.38M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -157.51M | -165.76M | -173.61M | -177.90M |
| Treasury Stock | -30.10M | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 15.00K | -30.00K | -10.00K | 19.00K |
| Total Capitalization | 126.33M | 115.36M | 86.11M | 68.51M |
| Total Equity | 126.33M | 115.36M | 86.11M | 68.51M |
| Total Liabilities & Stock Equity | 153.73M | 143.00M | 110.86M | 88.11M |
| Total Common Shares Outstanding | 29.95M | 29.76M | 29.01M | 28.69M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 984.07K | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 30.33M | 29.40M | 28.82M | 28.56M |
| Diluted Weighted Shares Outstanding | 30.33M | 30.75M | 29.65M | 28.56M |
| Number of Employees | 612 | 511 | 472 | 453 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with GHDX
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
Latest GHDX Headlines from TheStreet
- Top Insider Trades: DXM, SPB, AMTD, GHDX 05.17.13 | 08:05 am
- 5 Stocks Insiders Love Right Now 05.15.13 | 12:05 pm
- Top Insider Trades: GHDX WES GGP X 05.15.13 | 09:05 am
- Tech That Disrupts Our Lives for the Better 05.10.13 | 02:05 pm
- GHDX Crosses Above Key Moving Average Level 05.02.13 | 04:05 pm
- 4 Stocks Rising on Unusual Volume 03.29.13 | 07:03 am
- Top Insider Trades: GHDX, CLMS, IRM, FAST 02.22.13 | 09:02 am
- 5 Stocks With Big Insider Buying 02.13.13 | 12:02 pm
- 5 Stocks Poised for Breakouts 01.04.13 | 01:01 pm
- Short Sellers Are More Bullish About These Hedge Fund Favorites 12.20.12 | 04:12 pm
Press Releases for GHDX
- Genomic Health Announces Ten Studies Covering Breast, Colon And Prostate Cancers Accepted For Presentation At The American Society Of Clinical Oncology (ASCO) Annual Meeting - PR Newswire 05.21.13 | 08:05 am
- Genomic Health Announces Medicare Expanded Coverage Policy For Oncotype DX® Breast Cancer Test To Include Ductal Carcinoma In Situ (DCIS) Diagnosis - PR Newswire 05.10.13 | 04:05 pm
- Genomic Health Announces Availability Of Oncotype DX® Prostate Cancer Test With Potential To Triple The Number Of Patients Who Can Confidently Choose Active Surveillance And Avoid Side Effects Of Invasive Treatments - PR Newswire 05.08.13 | 08:05 am
- Genomic Health Announces Availability Of Oncotype DX® Prostate Cancer Test With Potential To Triple The Number Of Patients Who Can Confidently Choose Active Surveillance And Avoid Side Effects Of Invasive Treatments - PR Newswire 05.08.13 | 12:05 am
- Genomic Health To Present At Bank Of America Merrill Lynch Health Care Conference - PR Newswire 05.07.13 | 04:05 pm
- Genomic Health And ECOG-ACRIN Cancer Research Group Announce Publication Of Positive DCIS Validation Study In The Journal Of The National Cancer Institute - PR Newswire 05.02.13 | 04:05 pm
- Genomic Health Announces Investor Webcast And Conference Call To Review Positive Clinical Validation And Development Of The Oncotype DX® Prostate Cancer Test On Wednesday, May 8, 2013 - PR Newswire 05.01.13 | 04:05 pm
- Genomic Health To Announce First Quarter 2013 Financial Results And Host Conference Call On Thursday, May 2, 2013 - PR Newswire 04.25.13 | 08:04 am
- Genomic Health Announces Publication Of Second Positive Validation Of Oncotype DX Colon Cancer Test Confirming Its Value Beyond Conventional Markers - PR Newswire 04.17.13 | 08:04 am
- Genomic Health To Address One Of The Most Significant Needs In Men's Health With The Oncotype DX® Prostate Cancer Test - PR Newswire 04.03.13 | 08:04 am
Partner Headlines for GHDX
- U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying - Benzinga 05.18.13 | 03:05 pm
- Genomic Health Announces Medicare Expanded Coverage Policy for Oncotype DX® Breast Cancer Test - Benzinga 05.10.13 | 04:05 pm
- Genomic Health Earnings: Here’s Why the Stock is Down Now - Wall St. Cheat Sheet 05.02.13 | 08:05 am
- Genomic Health, Inc. Enters Oversold Territory - Tale of the Tape - NASDAQ 09.12.12 | 03:09 pm
- Cepheid Remains Neutral - Analyst Blog - NASDAQ 08.22.12 | 06:08 pm
- Agilent Wins Patent in US - Analyst Blog - NASDAQ 08.21.12 | 07:08 pm
- Genomic Health Back to Neutral - Analyst Blog - NASDAQ 08.20.12 | 11:08 pm
- Genomic Health Beats on EPS - Analyst Blog - Zacks 08.09.12 | 10:08 am
- CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares - GuruFocus 07.13.12 | 02:07 pm
- Medical Sector Shows Muscle With SXC Health, Cerner - Investor's Business Daily 06.21.12 | 06:06 pm
